VIEMED HEALTHCARE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 76.64K shares, a 77.26% decline year-over-year.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 80.95K shares, a 3947.75% increase year-over-year.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 14.00K shares, a 22.22% decline year-over-year.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 353.00K shares, a 25.62% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 281.00K shares, a 14.23% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 246.00K shares, a 196.39% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 83.00K shares, a 196.43% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 76.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | 171.60K shares derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 80.95K shares 10-Q · filed 2026-05-05 | 431.95K shares derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 353.00K shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 14.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 552.00K shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-06-30 | 337.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 556.00K shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-03-31 | 2.00K shares 10-Q · filed 2025-05-07 | 223.00K shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-12-31 | 199.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 281.00K shares 10-K · filed 2026-03-04 |
| 2024-09-30 | 18.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 99.00K shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | 4.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 82.00K shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | 60.00K shares 10-Q · filed 2024-05-06 | 198.00K shares derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | 17.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 246.00K shares 10-K · filed 2026-03-04 |
| 2023-09-30 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | 296.91K shares derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-06-30 | 120.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 311.00K shares derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-03-31 | 108.00K shares 10-Q · filed 2023-05-08 | 191.00K shares derived: sum of 4 quarters · filed 2025-03-10 |
| 2022-12-31 | 67.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | 83.00K shares 10-K · filed 2025-03-10 |
| 2022-09-30 | 15.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 15.09K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 0.00 shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-03 | 11.00K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 28.00K shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 68.00K shares derived: sum of 4 quarters · filed 2022-03-07 |
| 2021-06-30 | 11.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 70.00K shares derived: sum of 4 quarters · filed 2022-03-07 |
| 2021-03-31 | 17.00K shares 10-Q · filed 2021-05-03 | 655.00K shares derived: sum of 4 quarters · filed 2022-03-07 |
| 2020-12-31 | 40.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | 643.00K shares 10-K · filed 2022-03-07 |
| 2020-09-30 | 2.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 603.00K shares derived: sum of 4 quarters · filed 2021-03-03 |
| 2020-06-30 | 596.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 636.00K shares derived: sum of 4 quarters · filed 2021-03-03 |
| 2020-03-31 | 5.00K shares 10-Q · filed 2020-05-05 | |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | 42.00K shares 10-K · filed 2021-03-03 |
| 2019-09-30 | 35.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |